Immunotherapy News
Get the latest news in using immunotherapy to treat colorectal cancer.
Articles & Resources
Sort By: Guide Picks | Alphabetical | Recent Up a category
Avastin Warning
FDA and Genentech recently issued a drug warning to healthcare providers regarding Avastin. They have found new risks associated with the drug. Reported August 17, 2004.
FDA Approves Avastin for Treatment of Colorectal Cancer
Today, the U.S. Food and Drug Administration approved Avastin (bevacizumab) as a treatment for colon or rectal cancer that has spread to other parts of the body. This is the first drug ever to be approved that works by choking off a tumor’s blood supply. Reported February 26, 2004.
New Pamphlet Explains Biological Therapy
The National Cancer Institute has revised its informational pamphlet that explains biological therapy, also known as immunotherapy. The pamphlet discusses what biological therapy is, how it works, who it's for, and more. Reported April 11, 2004.
|
|
|
|
